Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Patrick Soon‐Shiong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4682-8298; OpenAlex author ID A5087962211. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Recurrent pancreatic cancer treated with N-803 and PD-L1 t-haNK followed by an EGFR-targeted nanocell drug conjugate. Last author DOI 10.1093/oncolo/oyae267↗
  2. Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancre… Last author DOI 10.3389/fonc.2025.1472714↗
  3. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. Co-author DOI 10.1200/jco.2011.36.5742↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tara Elisabeth Seery · 2 shared papers, 2025 · strength 0.55
  2. Sandeep Bobby Reddy · 1 shared paper, 2025 · strength 0.28
  3. Katayoun Moini · 1 shared paper, 2025 · strength 0.27
  4. Himanshu N. Brahmbhatt · 1 shared paper, 2025 · strength 0.27
  5. Mitesh J. Borad · 1 shared paper, 2011 · strength 0.02
  6. N.V. Rajeshkumar · 1 shared paper, 2011 · strength 0.02
  7. Vuong N. Trieu · 1 shared paper, 2011 · strength 0.02
  8. Ronald Lee Korn · 1 shared paper, 2011 · strength 0.02
  9. Ramesh K. Ramanathan · 1 shared paper, 2011 · strength 0.02
  10. Manuel M. Hidalgo · 1 shared paper, 2011 · strength 0.02
  11. Anirban Maitra · 1 shared paper, 2011 · strength 0.02
  12. Daniel D. Von Hoff · 1 shared paper, 2011 · strength 0.02
  13. Daniel A. Laheru · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.